Vedolizumab May Offer Hope for People with Colitis or Crohn’s Disease

One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.

Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.

The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.

During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.

Our Blogs

Do Lifestyle or Genetic Factors Affect the Risk of Acid Reflux More?

Back to BlogsAcid reflux is a common condition that affects millions of people worldwide. Also known as gastroesophageal reflux disease (GERD), it occurs when stomach acid flows back into the esophagus, causing discomfort and potentially damaging the lining of the...

Does GERD Affect Young Adults?

Back to BlogsGERD, also called heartburn or acid reflux, is an extremely common digestive condition afflicting about 20% of adults worldwide. It consists of an uncomfortable or painful burning sensation in your chest caused by stomach acid leaking into your esophagus....

What Kinds of Processed Foods Should I Avoid?

Back to BlogsIf you’ve ever gotten into dieting or nutrition, you’ve probably heard this adage: whole foods are good, processed foods are bad. This is generally true, but what’s the difference between whole and processed foods? And what types of processed foods should...